IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — APYX

Balance Sheet

(in millions USD)
MetricQ1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021
Cash & Equivalents31.1425.1429.3031.0128.0132.6837.2822.1318.4816.2614.8320.0626.2330.9034.6739.54
Accounts Receivable12.7613.0011.2511.6513.0412.7112.4912.6512.079.979.0910.3412.3611.448.997.68
Inventory9.549.158.197.699.009.329.8011.2911.1710.9512.049.687.026.045.274.46
Total Current Assets54.8048.7949.9251.8552.1656.6761.9350.1552.8952.6846.3150.5354.8159.8861.5863.04
Property, Plant & Equipment2.242.392.051.911.911.921.782.092.122.116.816.846.666.416.476.60
Total Non-current Assets*6.356.776.556.548.568.728.799.309.544.108.968.958.197.898.028.05
Total Assets63.0357.3758.1960.1660.7265.3970.7159.4562.4356.7855.2759.4763.0067.7769.6071.10
Accounts Payable2.633.222.892.311.912.352.102.052.661.912.072.592.563.042.802.28
Total Current Liabilities9.4510.9810.579.519.5610.6410.5610.2919.0318.5311.1911.3511.6011.7110.759.73
Long-term Debt37.5037.5037.5037.5037.5033.6333.419.018.898.78------------
Total Non-current Liabilities*40.4940.3140.1740.0139.9739.8339.7015.576.672.041.861.961.551.401.171.20
Total Liabilities49.9451.2950.7349.5249.5250.4750.2525.8625.7020.5713.0513.3113.1513.1111.9210.93
Retained Earnings(91.23)(87.82)(85.84)(82.06)(73.28)(68.58)(62.02)(44.84)(40.21)(39.22)(29.69)(23.92)(18.50)(10.55)(6.33)(2.28)
Total Stockholder Equity12.835.857.2510.5111.0414.7520.2533.3536.6036.0541.9945.9149.5654.3557.3660.04

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Total Revenue12.4919.1612.8811.379.4314.2211.4912.1510.2414.6611.9813.5712.1412.619.1110.2912.4916.8211.8311.22
Cost of Revenue4.577.174.584.293.775.264.534.664.305.734.004.294.574.373.363.384.274.673.783.69
Gross Profit7.9312.008.307.085.678.966.957.495.958.937.989.287.578.245.766.918.2212.158.067.53
Research & Development0.770.940.800.820.801.121.141.421.401.251.281.201.121.251.061.071.160.951.181.08
Selling, General & Admin3.584.633.664.143.384.834.294.844.906.724.845.385.265.814.674.545.476.024.614.26
Total Operating Expenses8.8411.999.139.668.7212.0110.5913.0412.5614.7112.6213.2113.1814.1711.5412.8914.0913.8412.0211.58
Operating Income(0.91)0.01(0.83)(2.57)(3.05)(3.05)(3.63)(5.55)(6.61)(5.78)(4.64)(1.24)(5.61)(5.93)(5.78)(5.98)(5.87)(1.69)(3.97)(4.04)
Interest Expense--------------1.431.401.120.590.540.230.000.000.000.010.000.000.00
Pretax Income(2.00)(1.15)(1.88)(3.69)(4.12)(4.57)(4.66)(6.54)(7.54)(9.54)(4.99)(0.95)(5.80)(5.91)(5.74)(5.35)(5.90)(1.88)(4.16)(3.94)
Tax Provision0.140.090.080.050.050.090.060.050.050.09(0.32)0.07(2.27)0.150.050.100.070.130.070.11
Net Income(2.11)(1.30)(1.98)(3.78)(4.15)(4.63)(4.70)(6.56)(7.58)(9.61)(4.63)(0.99)(3.48)(6.05)(5.76)(5.43)(5.94)(2.00)(4.22)(4.05)
Basic EPS(0.05)(0.03)(0.05)(0.09)(0.10)(0.11)(0.14)(0.19)(0.22)(0.28)(0.13)(0.03)(0.10)(0.17)(0.17)(0.16)(0.17)(0.06)(0.12)(0.12)
Diluted EPS--------------(0.19)(0.22)(0.28)(0.13)(0.03)(0.10)(0.17)(0.17)(0.16)(0.17)(0.06)(0.12)(0.12)

Cash Flow Statement

(in millions USD)
MetricQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Operating Cash Flow(0.57)(2.53)(3.54)(1.23)(0.70)(2.94)(4.44)(4.33)(6.34)(2.21)3.70(4.85)(1.88)(4.53)(5.36)(5.87)(4.52)0.21(3.60)(5.01)
Capital Expenditures0.060.280.520.270.060.250.150.290.040.090.170.160.110.140.190.400.280.330.170.03
Free Cash Flow*(0.63)(2.80)(4.05)(1.50)(0.76)(3.18)(4.59)(4.62)(6.38)(2.31)3.52(5.01)(1.99)(4.67)(5.55)(6.27)(4.80)(0.12)(3.77)(5.03)
Investing Cash Flow(0.06)(0.28)(0.52)(0.26)(0.05)(0.24)(0.15)(0.29)(0.04)(0.09)(0.17)7.11(0.11)(0.14)(0.19)(0.40)(0.28)(0.33)(0.17)(0.03)
Financing Cash Flow0.089.490.050.030.036.76-0.00-0.00-0.0023.840.160.058.11(0.01)0.130.000.10(0.04)(0.03)0.16

* Derived from reported values